EGO Pharmaceuticals is set to double the production of its therapeutic skincare products following the launch of a $156 million investment in its manufacturing capabilities at Braeside, Melbourne.
It includes the opening of the state-of-the-art Zorzi Innovation Centre (ZInC), The Green Core sustainability project, and the installation of a new cream and tube filling line that will increase manufacture and production from 25 million units per annum to 50 million units.
Set to be completed by 2027, the project will also double capacity at the company’s Global Distribution Centre in Dandenong.
In 2024, Ego’s flagship QV brand was Australia’s number one skincare brand in pharmacy and grocery channels, according to sales data, positioning QV as the highest-selling skincare brand, with sales exceeding $133 million.
Ego Pharmaceuticals has been manufacturing skincare products in Victoria for more than 70 years and employs approximately 500 people in the state, supporting hundreds more through a strong local supply chain.
“We’re incredibly proud to officially open these new facilities, which represent a major step forward not just for Ego Pharmaceuticals, but for Australian manufacturing more broadly,” said Ego Pharmaceuticals MD, Alan Oppenheim (pictured).
“While the majority of global skincare companies manufacture offshore, we’ve chosen a different path – one that backs Australian jobs, science and ingenuity.
“This investment is more than steel and machinery – it’s a long-term vote of confidence in what Australian expertise can deliver on a global stage.”
With key export markets such as the UK, China, UAE, Saudi Arabia and Singapore, Ego generates half of its $300 million annual turnover from exports and is a major contributor to Victoria’s economy.
Backed by $35 million of State Government funding, the initiative will create 90 new jobs and boost exports.
“Victoria’s health tech sector is thriving, and this $35 million redevelopment project is a prime example,” said Premier of Victoria, Jacinta Allan.
“We backed Ego Pharmaceuticals to grow because we know investments like this mean more local jobs, more exports, and a stronger economy.” KB
The post Ego expands production with $156m boost appeared first on Pharmacy Daily.
